Arbutus Medical is a technology company.
Arbutus Medical has raised $1.0M across 1 funding round.
Arbutus Medical has raised $1.0M in total across 1 funding round.
Arbutus Medical has raised $1.0M in total across 1 funding round.
Arbutus Medical's investors include Joe Greenstein, Richard Chen, Saki Georgiadis.
Arbutus Medical is a Vancouver-based medical device company that develops affordable, sterile orthopedic surgical tools and procedure kits to streamline trauma care, reduce costs, and improve efficiency in hospitals worldwide.[1][8] Founded to address tool shortages in low-resource settings, it serves orthopedic surgeons, trauma centers, emergency departments, and military/veterinary users by solving delays in accessing sterile power tools and consumables, enabling faster patient treatment—its products have supported over 85,000 surgeries across 40 countries.[1][4] Key offerings include the patented DrillCover technology (a sterile enclosure for consumer drills like DEWALT and Makita, FDA-cleared and Health Canada-licensed), TrakPak® (sterile skeletal traction kits), QuikBow® pin tensioner, SteriTrak® kit, and Digit Revision SwiftKit™ for fingertip procedures, with strong growth via rapid prototyping and frugal innovation.[1][2][3][8]
Arbutus Medical was founded in 2014 by orthopedic trauma surgeons from Vancouver General Hospital and biomedical researchers who identified a critical gap: low-resource hospitals lacked affordable, reliable surgical drills.[1] CEO and Co-Founder Lawrence Buchan (orthopedic surgeon) and Sr. Director of Product and Co-Founder Michael Cancilla led the initial innovation—a partnership with DEWALT to create DrillCover technology, converting non-sterile power tools into sterile surgical devices.[1] Early traction came from deployments in low- and middle-income countries, military field hospitals, and veterinarians, evolving from drills to a full portfolio of sterile kits amid rising demand in North American trauma centers post-COVID.[1][3][4] Pivotal moments include licensing in 2015 and recent launches like QuikBow® (2023, developed in four months using 3D printing) and TrakPak®, reflecting a shift to ER-specific efficiencies.[2][3]
Arbutus Medical rides the wave of frugal medtech innovation, addressing global surgery access gaps highlighted by the Lancet Commission’s Global Surgery 2030 (20 million annual deaths from lack of care) and post-COVID supply strains in trauma care.[3][4] Timing aligns with rising ER volumes, tool sterilization bottlenecks (e.g., 75% of U.S. Level I/II trauma centers do 175+ skeletal tractions yearly but lack ER drills), and demand for single-use kits amid infection control priorities.[3] Market tailwinds include 3D printing for agile manufacturing and partnerships (DEWALT, Formlabs), positioning it against expensive OEM tools while influencing ecosystems via endorsements from orthopedic bodies and use in 40 countries.[2][4] It democratizes high-quality orthopedics, boosting efficiency in high-volume trauma settings and low-resource regions.
Arbutus Medical's momentum—fueled by consumables like TrakPak® (bundled free drills) and a growing kit portfolio—positions it for scaled adoption in North American trauma centers and global aid programs.[1][6] Upcoming trends like AI-driven procedure optimization and expanded 3D/additive manufacturing will accelerate iterations, while rising trauma caseloads (ER throughput pressures) favor its efficiency edge.[2][3] Influence may evolve through deeper military/humanitarian integrations and potential acquisition by medtech giants eyeing affordable sterile tech, solidifying its role as a streamlined surgery enabler from Vancouver origins to worldwide impact.[4][5]
Arbutus Medical has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2020 | $1.0M Seed | Joe Greenstein, Richard Chen, Saki Georgiadis |